![conference banner](/images/conference-banner.jpeg)
Abstract
Brain-related disorders are one of the world’s most important and complex health problems today. These brain-related disorders are responsible for a massive number of morbidities and death all around the world. However, researchers have devoted a large amount of time to investigating these diseases and found positive results; nevertheless, there are currently quite a few medications available to treat them. Emodin (EM), a polyphenol compound, has many health benefits. It is a biologically active monomer derived from rhubarb root that exhibits anti-inflammation, anti-oxidation, anticancer, and neuroprotective properties. A series of preclinical trials have shown EM to have protective benefits against many brain-related diseases. This review has evaluated the potential of EM as a pharmacological agent for the treatment and management of various brain-related disorders based on the findings of multiple pre-clinical studies and taking into account the compound’s therapeutic properties.
Keywords: EM, Alzheimer’s disease, parkinson’s disease, stress, epilepsy, depression, cerebral ischemia, glioblastoma, intra-cerebral haemorrhage, traumatic brain injury.
[http://dx.doi.org/10.1155/2020/1562915] [PMID: 32832542]
[http://dx.doi.org/10.1242/dmm.030205] [PMID: 28468935]
[http://dx.doi.org/10.3892/mmr.2016.4948] [PMID: 26935478]
[PMID: 16940925]
[http://dx.doi.org/10.1142/S0192415X96000189] [PMID: 8874670]
[http://dx.doi.org/10.1007/s11064-016-2018-6] [PMID: 27538959]
[http://dx.doi.org/10.1021/jf203290r] [PMID: 22145830]
[http://dx.doi.org/10.1093/ijnp/pyy090] [PMID: 30407508]
[http://dx.doi.org/10.1016/j.fitote.2014.06.007] [PMID: 24932776]
[http://dx.doi.org/10.1111/cns.13399] [PMID: 32488963]
[http://dx.doi.org/10.1016/j.bcp.2005.04.026] [PMID: 15941563]
[http://dx.doi.org/10.1158/1535-7163.MCT-15-0987] [PMID: 27196773]
[http://dx.doi.org/10.3892/mmr.2017.6254] [PMID: 28260110]
[http://dx.doi.org/10.1016/j.canlet.2013.08.023] [PMID: 23962559]
[http://dx.doi.org/10.1016/j.jep.2016.04.058] [PMID: 27151150]
[http://dx.doi.org/10.3390/ijms22179522] [PMID: 34502424]
[http://dx.doi.org/10.1016/j.jpba.2012.07.031] [PMID: 22944356]
[http://dx.doi.org/10.1016/j.fsi.2014.02.018] [PMID: 24631735]
[http://dx.doi.org/10.1002/ptr.5631] [PMID: 27188216]
[http://dx.doi.org/10.1562/0031-8655(2002)0750346PAPOAE2.0.CO2] [PMID: 12003123]
[PMID: 20055157]
[http://dx.doi.org/10.1016/j.toxlet.2019.02.007] [PMID: 30771440]
[http://dx.doi.org/10.1016/j.mrgentox.2009.06.004] [PMID: 19559101]
[http://dx.doi.org/10.1016/j.fct.2011.12.018]
[http://dx.doi.org/10.1002/ptr.6532] [PMID: 31680350]
[http://dx.doi.org/10.1177/0271678X221111600] [PMID: 35765984]
[http://dx.doi.org/10.3892/ijmm.2021.5070] [PMID: 34878154]
[http://dx.doi.org/10.1080/14656566.2021.1912013] [PMID: 33823726]
[PMID: 25206430]
[http://dx.doi.org/10.1039/D1FO01144H] [PMID: 34286782]
[http://dx.doi.org/10.1016/j.jep.2014.03.002] [PMID: 24685586]
[http://dx.doi.org/10.1080/21691401.2019.1633339] [PMID: 31257935]
[http://dx.doi.org/10.3389/fphar.2018.00943] [PMID: 30233364]
[http://dx.doi.org/10.1111/jphp.12885] [PMID: 29424025]
[http://dx.doi.org/10.3390/ijms21082899] [PMID: 32326191]
[http://dx.doi.org/10.1016/j.ejphar.2007.08.033] [PMID: 17897641]
[http://dx.doi.org/10.1016/j.ctrv.2019.101896] [PMID: 31541850]
[http://dx.doi.org/10.1016/j.tins.2020.10.014] [PMID: 33234347]
[http://dx.doi.org/10.1188/16.CJON.S1.2-8] [PMID: 27668386]
[http://dx.doi.org/10.1007/s10637-019-00764-w] [PMID: 30924024]
[http://dx.doi.org/10.1007/s00018-005-4425-8] [PMID: 15747063]
[http://dx.doi.org/10.1080/10286020.2013.818982] [PMID: 23869465]
[http://dx.doi.org/10.1124/jpet.109.153007] [PMID: 19549930]
[http://dx.doi.org/10.1016/j.intimp.2004.07.012] [PMID: 15531293]
[http://dx.doi.org/10.1002/tox.22622] [PMID: 30218594]
[PMID: 16077936]
[http://dx.doi.org/10.1089/scd.2014.0210] [PMID: 25229646]
[PMID: 24969876]
[PMID: 36974407]
[http://dx.doi.org/10.1016/j.pharmthera.2023.108398] [PMID: 37001735]
[http://dx.doi.org/10.3390/ijms19103195] [PMID: 30332818]
[http://dx.doi.org/10.1055/s-0034-1383410] [PMID: 25590369]
[http://dx.doi.org/10.3892/mmr.2020.11747] [PMID: 33300068]
[http://dx.doi.org/10.1016/j.brainres.2010.05.079] [PMID: 20573598]
[http://dx.doi.org/10.14715/cmb/2019.65.5.5] [PMID: 31304903]
[http://dx.doi.org/10.1016/j.bmcl.2014.10.049] [PMID: 25453793]
[http://dx.doi.org/10.1212/CON.0000000000000672] [PMID: 30516598]
[http://dx.doi.org/10.1080/14737175.2019.1623671] [PMID: 31188036]
[http://dx.doi.org/10.12688/f1000research.16357.1] [PMID: 30906532]
[http://dx.doi.org/10.3109/08923973.2010.549135] [PMID: 21275776]
[http://dx.doi.org/10.1152/physrev.00045.2019] [PMID: 32584191]
[http://dx.doi.org/10.36076/ppj.2018.3.E225] [PMID: 29871378]
[http://dx.doi.org/10.1016/j.brainresbull.2011.01.017] [PMID: 21303687]
[http://dx.doi.org/10.2147/JPR.S290681] [PMID: 33707969]
[http://dx.doi.org/10.1007/s11302-017-9583-2] [PMID: 28840511]
[http://dx.doi.org/10.2174/1871527315666160815093525] [PMID: 27528468]
[http://dx.doi.org/10.1007/s11064-014-1395-y] [PMID: 25064046]
[http://dx.doi.org/10.1016/j.neuropharm.2005.02.003] [PMID: 15992585]
[http://dx.doi.org/10.1080/01616412.2020.1853989] [PMID: 33274693]
[http://dx.doi.org/10.18632/aging.203072] [PMID: 34051074]
[http://dx.doi.org/10.3389/fcell.2021.696619] [PMID: 34381778]
[http://dx.doi.org/10.1016/j.mce.2018.03.009] [PMID: 29577942]
[http://dx.doi.org/10.2147/DMSO.S299375] [PMID: 33776462]
[http://dx.doi.org/10.1002/tox.22928] [PMID: 32293791]
[http://dx.doi.org/10.1042/BSR20182378] [PMID: 31023967]
[http://dx.doi.org/10.1016/j.pbb.2010.09.009] [PMID: 20863847]
[http://dx.doi.org/10.1016/j.ejphar.2013.02.021] [PMID: 23499696]
[PMID: 31966486]
[http://dx.doi.org/10.1016/j.jep.2007.05.004] [PMID: 17572029]
[http://dx.doi.org/10.1089/rej.2009.0877] [PMID: 19929256]
[PMID: 26045880]
![Wayfinder Image](/images/wayfinder.jpg)